3,301 results match your criteria: "REM Sleep Behavior Disorder"

Subthalamic γ Oscillation Underlying Rapid Eye Movement Sleep Abnormality in Parkinsonian Patients.

Mov Disord

December 2024

National Engineering Research Center of Neuromodulation, School of Aerospace Engineering, Tsinghua University, Beijing, China.

Background: Abnormal rapid eye movement (REM) sleep, including REM sleep behavior disorder (RBD) and reduced REM sleep, is common in Parkinson's disease (PD), highlighting the importance of further study on REM sleep. However, the biomarkers of REM disturbances remain unknown, leading to the lack of REM-specific neuromodulation interventions.

Objective: This study aims to investigate the neurophysiological biomarkers of REM disturbance in parkinsonian patients.

View Article and Find Full Text PDF

Brain Network Analysis Reveals Hemispheric Aberrant Topology in Patients with idiopathic REM Sleep Behavior Disorder.

Brain Res Bull

December 2024

Key Laboratory for Biomedical Engineering of Ministry of Education of China, Zhejiang University, Hangzhou 310007, Zhejiang, China; Department of Rehabilitation, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 310007, Zhejiang, China. Electronic address:

Idiopathic rapid eye movement sleep behavior disorder (iRBD) is recognized as a prodromal stage of neuro-degenerative disease. While brain network analysis is a well-documented approach for characterizing disease-related dysfunctions, the specific patterns in iRBD, particularly those related to hemispheric aberrations remain largely unexplored. To address this gap, this study investigated the topological abnormalities of multi-band EEG networks in patients with iRBD.

View Article and Find Full Text PDF

Objective: We prospectively evaluated how well combinations of signs and symptoms can identify individuals in the prodromal phase of Parkinson's disease (PD).

Methods: The study comprised 6,108 men who underwent repeated assessments of key prodromal features and were prospectively followed for the development of PD. Two composite measures of prodromal PD were evaluated: (i) the co-occurrence of constipation, probable rapid eye movement (REM) sleep behavior disorder (pRBD), and hyposmia, and (ii) the probability of prodromal PD based on the Movement Disorders Society (MDS) research criteria.

View Article and Find Full Text PDF

Rapid Eye Movement (REM) sleep behavior disorder (RBD) affects nearly half of Parkinson's disease (PD) patients. However, the structural heterogeneity within the brainstem, which regulates REM sleep, remains largely unexplored in PD. Our objective was to identify distinct PD subtypes based on microstructural characteristics in the brainstem and examine their associations with the severity of RBD.

View Article and Find Full Text PDF

Background: α-Synuclein seed amplification assay on cerebrospinal fluid (CSF-αSyn-SAA) has shown high accuracy for Parkinson's disease (PD) diagnosis. The analysis of CSF-αSyn-SAA parameters may provide useful insight to dissect the heterogeneity of synucleinopathies.

Objective: To assess differences in CSF-αSyn-SAA amplification parameters in participants with PD stratified by rapid eye movement (REM) sleep behavior disorder (RBD), dysautonomia, GBA, and LRRK2 variants.

View Article and Find Full Text PDF

Background: Loss of dorsolateral nigral hyperintensity (DNH) in iron-sensitive sequences of Magnetic Resonance Imaging (MRI), also described as "swallow tail sign" (STS) loss, has shown promising diagnostic value in Parkinson's Disease (PD) and Atypical Parkinsonian Syndromes (APS).

Objective: To conduct a bibliometric analysis on substantia nigra MRI and a systematic review on the clinical utility of STS visual assessment on Susceptibility-Weighted Imaging in various clinical entities.

Methods: VOSviewer's keyword co-occurrence network was employed using Web of Science (WOS).

View Article and Find Full Text PDF

Isolated rapid-eye-movement sleep behavior disorder (iRBD) is a strong predictor of Parkinson's disease and Dementia with Lewy bodies. Previous studies indicate that cortical atrophy in iRBD patients may be linked to cognitive impairment, but the pattern of atrophy is inconsistently reported. This study aimed to elucidate cortical atrophy patterns in a cognitively unimpaired iRBD cohort, focusing on regions associated with cognitive functions, particularly the cuneus/precuneus, and evaluated the predictive value for future phenoconversion.

View Article and Find Full Text PDF

Background: The α-Synuclein Origin and Connectome (SOC) model recently proposed two different Parkinson's Disease (PD) phenotypes clinically based on the relationship between REM sleep behavior disorder (RBD) and motor symptoms' onset: a "body first" phenotype and a "brain first" phenotype in which RBD precedes or may follow the motor onset, respectively. A higher burden of non-motor symptoms as well as a more symmetrical clinical presentation have also been predicted in the body-first phenotype. This point has been poorly assessed through semi-quantitative striatal dopaminergic functional imaging to date.

View Article and Find Full Text PDF

The motor stage of idiopathic Parkinson's disease (iPD) can be preceded for years by a prodromal stage characterized by non-motor symptoms like REM sleep behavior disorder (RBD). Here, we show that multiple stages of iPD, including the pre-motor prodromal stage, can be stratified according to the inflammatory and immunometabolic responses to stimulation of peripheral blood mononuclear cells . We identified increased stimulation-dependent secretion of TNF, IL-1β, and IL-8 in monocytes from RBD patients and showed diminished proinflammatory cytokine secretion in monocytes and T cells in early and moderate stages of PD.

View Article and Find Full Text PDF

Background: Rapid eye movement sleep behavior disorder (RBD) is an established prodrome and symptom of synucleinopathies. The pathophysiology of this disorder has been well studied but there is a lack of functional imaging data to illustrate the dysfunction in vivo.

Objectives: We aimed to investigate the functional changes of RBD, by performing ictal REM sleep SPECT, comparing subjects with Parkinson's Disease (PD) and evidence of RBD to subjects with PD and no RBD.

View Article and Find Full Text PDF

Wider and faster degeneration of white matter in Parkinson's disease with possible REM sleep behaviour disorder.

Sleep Med

December 2024

Department of Radiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang, China; Joint Laboratory of Clinical Radiology, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. Electronic address:

Background: In Parkinson's disease (PD), rapid eye movement (REM) sleep behaviour disorder (RBD) signifies a poorer prognosis, yet its impact on white matter (WM) degeneration remains unclear. The study examined the effect of RBD on WM alterations in PD progression.

Methods: The study included 45 PD patients with possible RBD (PD-pRBD), 38 PD patients without possible RBD (PD-npRBD), and 79 healthy controls (HC).

View Article and Find Full Text PDF
Article Synopsis
  • This study investigates whether type 2 diabetes mellitus (T2DM) causes isolated REM sleep behavior disorder (iRBD), analyzing genetic data from nearly 9,500 samples.
  • The analysis reveals a genetic correlation between T2DM and iRBD, with T2DM and high blood glucose levels identified as significant risk factors for developing iRBD, even after accounting for other influences.
  • Findings suggest that T2DM may contribute to iRBD indirectly through immune system changes, pointing to potential health implications and new avenues for research and treatment.
View Article and Find Full Text PDF
Article Synopsis
  • Idiopathic REM sleep behavior disorder (iRBD) is linked to alpha-synucleinopathies, and the study aimed to evaluate autonomic nervous system (ANS) dysfunction in individuals with iRBD and its potential to predict clinical progression.
  • In a study of 25 iRBD patients, 28% developed synucleinopathy, primarily Parkinson's disease, with many exhibiting abnormal ANS test results; those who progressed had significantly higher rates of dysfunction compared to those who did not.
  • Results indicate that both symptomatic and subtle ANS dysfunctions are prevalent in iRBD, and specific adrenergic system issues may signal a higher short-term risk of developing synucleinopathy.
View Article and Find Full Text PDF

Sleep related injury and its correlates in isolated rapid eye movement sleep behavior disorder.

Sleep Med

November 2024

Department of Psychiatry, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong Special Administrative Region of China; Li Chiu Kong Family Sleep Assessment Unit, Department of Psychiatry, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong Special Administrative Region of China; Li Ka Shing Institute of Health Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong. Electronic address:

Article Synopsis
  • This study aimed to find out what factors contribute to sleep-related injuries (SRI) and persistent sleep-related injuries (pSRI) in patients with isolated rapid eye movement sleep behavior disorder (iRBD).
  • A retrospective review of 388 iRBD patients showed that 83% reported a history of SRI, with some suffering severe injuries, and factors like depressive symptoms, alcohol consumption, and certain EMG activity were linked to these injuries.
  • Despite treatment, 18% of patients continued to experience pSRI over an average follow-up of 5.1 years, highlighting the need for better safety measures and targeted screening for those at risk.
View Article and Find Full Text PDF

Background: Rapid eye movement (REM) sleep behavior disorder (RBD) may precede motor symptoms in Parkinson's disease (PD) by years. According to a recent hypothesis, premotor RBD (pRBD) is a marker of the PD body-first subtype, where synucleinopathy originates from the peripheral autonomic nervous system. Conversely, in the brain-first subtype, pathology would arise in the brain.

View Article and Find Full Text PDF
Article Synopsis
  • Charles Fisher was a groundbreaking researcher in sleep medicine who made significant contributions in various areas of sleep study, particularly concerning REM sleep in narcoleptic patients.
  • He was the first to document several key concepts, such as the effects of benzodiazepines on night terrors and the connection between REM sleep and sexual arousal.
  • Collaborating with notable figures like William C. Dement, Fisher’s work laid a foundation for understanding sleep disorders, behaviors, and cycles, influencing the field well beyond his era.
View Article and Find Full Text PDF

Polysomnography, the gold standard diagnostic tool in sleep medicine, is performed in an artificial environment. This might alter sleep and may not accurately reflect typical sleep patterns. While macro-structures are sensitive to environmental effects, micro-structures remain more stable.

View Article and Find Full Text PDF

Context-dependency of the REM sleep behavior disorder screening questionnaire - Clinical utility under scrutiny.

Parkinsonism Relat Disord

November 2024

Cognitive Neuroscience, Institute for Neuroscience and Medicine, INM-3, Research Centre Juelich, Juelich, Germany; Medical Psychology | Neuropsychology and Gender Studies, Center for Neuropsychological Diagnostics and Intervention (CeNDI), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany. Electronic address:

Introduction: The REM Sleep Behavior Disorder (RBD) Screening Questionnaire (RBDSQ) is a widely established screening tool for detecting isolated RBD (iRBD). However, its accuracy may depend on its application context, e.g.

View Article and Find Full Text PDF
Article Synopsis
  • Alpha-synuclein (α-syn) is a protein in the brain essential for cellular function, but it can misfold and aggregate, leading to dysfunction and cell death.
  • The accumulation of misfolded α-syn is linked to several neurodegenerative diseases, known as α-synucleinopathies, including Parkinson's disease and others.
  • Recent research suggests that SARS-CoV-2 infection could potentially trigger or worsen these diseases by promoting α-syn misfolding and related neurological symptoms.
View Article and Find Full Text PDF

Post-mortem neuropathology of idiopathic rapid eye movement sleep behaviour disorder: a case series.

Lancet Neurol

December 2024

Neurological Tissue Bank of the Biobank, FRCB-IDIBAPS, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain; Department of Pathology, Biomedical Diagnostic Center (CDB), Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain.

Article Synopsis
  • The study examines post-mortem brain tissues from individuals diagnosed with idiopathic REM sleep behavior disorder (IRBD) to investigate its potential link to neurodegenerative diseases, specifically focusing on signs of neuronal loss and the presence of key protein deposits.
  • Researchers analyzed samples from 20 participants, most of whom were diagnosed with Lewy body disease, while a small number had Parkinson's disease-related conditions, revealing significant findings of neuronal damage associated with α-synuclein proteins, particularly in brain regions controlling REM sleep.
  • While the sample size limited the statistical analysis, the outcomes suggest a strong correlation between IRBD and neurodegenerative diseases, emphasizing the importance of these pathological features for understanding the progression
View Article and Find Full Text PDF

REM sleep behaviour disorder and α-synuclein.

Lancet Neurol

December 2024

Department of Psychiatry and Psychology, Mayo Clinic, Jacksonville, FL, USA.

View Article and Find Full Text PDF

Longitudinal decline in DAT binding in Parkinson's disease: connections with sleep disturbances.

BMC Med

November 2024

Department of Neurology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou , Zhejiang, 310009, China.

Article Synopsis
  • The study examined how the dysfunction of the nigrostriatal dopamine system affects sleep disturbances in newly diagnosed Parkinson's disease patients, focusing on excessive daytime sleepiness and probable RBD.
  • Data was collected from 621 patients over four years through established sleep scales and dopamine transporter imaging.
  • Results showed a negative correlation between dopamine transporter binding ratios and sleep issues, suggesting that dopamine dysfunction and genetic factors (like the alpha-synuclein gene) significantly contribute to sleep disturbances in these patients.
View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to compare manual and automated methods for detecting REM sleep without atonia (RSWA) in patients with REM sleep behavior disorder (RBD) and a control group.
  • Researchers evaluated the accuracy of automated RSWA detection through in-laboratory and in-home recordings, finding high agreement with expert scoring and good reliability of results across multiple nights.
  • Results showed that automated detection provided a strong ability to differentiate between RBD patients and control subjects, suggesting it could be a useful tool for diagnosing RBD.
View Article and Find Full Text PDF

Characterization of Sleep Structure and Autonomic Dysfunction in REM Sleep Behavior Disorder.

IEEE Open J Eng Med Biol

May 2024

Department of Electronic, Information and BioengineeringPolitecnico di Milano 20156 Milano Italy.

Article Synopsis
  • REM Sleep Behavior Disorder (RBD) is linked to an increased risk of developing neurodegenerative diseases like Parkinson's and dementia, prompting a study of autonomic dysfunction in RBD patients.* -
  • The study used advanced methods to analyze sleep patterns and heart rate variability, revealing that RBD patients generally experience lower heart rate variability and are more likely to transition to lighter sleep stages.* -
  • Although RBD patients suffer from fragmented sleep and autonomic issues, those with Parkinson's displayed better sleep continuity, potentially due to relief from their PD symptoms during sleep.*
View Article and Find Full Text PDF
Article Synopsis
  • - Identifying early biomarkers for neurodegeneration is essential, especially in patients with idiopathic REM sleep behavior disorder (iRBD), where changes in CD4 T cells may indicate risk.
  • - A study followed iRBD patients to measure levels of specific transcription factors in CD4 T cells, using statistical methods to differentiate between those who converted to neurodegeneration and those who did not.
  • - The findings reveal that certain mRNA levels in CD4 T cells can serve as promising predictive biomarkers, with significant hazard ratios indicating higher and lower levels are linked to increased risk of phenoconversion in iRBD patients.
View Article and Find Full Text PDF